Sign In
Buy CHE
$444.11
+8.04 (+1.84%)
At Close: Jun 23, 2026
OPCH or CHE: Which Is the Better Value Stock Right Now?
12:45pm, Monday, 14'th Apr 2025
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two companies is the best option for
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
12:00pm, Tuesday, 01'st Apr 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following t
Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report?
12:36pm, Friday, 28'th Mar 2025
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
OPCH vs. CHE: Which Stock Is the Better Value Option?
12:40pm, Thursday, 20'th Mar 2025
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two stocks presents investors with th
OPCH or CHE: Which Is the Better Value Stock Right Now?
12:45pm, Tuesday, 04'th Mar 2025
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attrac
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
01:24pm, Monday, 03'rd Mar 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, a
Chemtrade Logistics Income Fund (CGIFF) Q4 2024 Earnings Call Transcript
02:09pm, Friday, 28'th Feb 2025
Chemtrade Logistics Income Fund (OTC:CGIFF) Q4 2024 Earnings Conference Call February 28, 2025 10:00 AM ET Corporate Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President and Ch
Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract
09:30am, Friday, 28'th Feb 2025
CHE's earnings and revenues beat estimates in the fourth quarter of 2024.
Chemed Corporation (CHE) Q4 2024 Earnings Call Transcript
02:10pm, Thursday, 27'th Feb 2025
Chemed Corporation (NYSE:CHE ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Execut
Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates
07:15pm, Wednesday, 26'th Feb 2025
Chemed (CHE) came out with quarterly earnings of $6.83 per share, beating the Zacks Consensus Estimate of $6.79 per share. This compares to earnings of $6.60 per share a year ago.
Chemed Reports Fourth-Quarter 2024 Results
04:15pm, Wednesday, 26'th Feb 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, t
Chemed Corporation Declares Quarterly Dividend of 50 Cents
01:30pm, Friday, 14'th Feb 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, paya
ADUS vs. CHE: Which Stock Is the Better Value Option?
12:46pm, Thursday, 13'th Feb 2025
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two stocks is more att
Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27
05:35pm, Tuesday, 11'th Feb 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2024, on Wednesday, February 26, 2025, foll
Should Investors Hold Chemed Stock in Their Portfolio Now?
10:06am, Tuesday, 04'th Feb 2025
CHE stays on investors' radar due to its robust prospects in the VITAS business and the resilient Roto-Rooter arm.
